HomeResearchCOVID-19

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/IJID.jpg
Effectiveness of different types of Masks in Aerosol Dispersion in SARS–CoV-2 Infection

Tanisali G, Sozak A, Bulut AS, Sander TZ, Dogan Ö, Dağ Ç, Gönen M, Can F, Demirci H, Ergönül Ö. Int J Infect Dis. 2021 June. doi:10.1016/j.ijid.2021.06.029.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/CMI.jpg
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis

Kayı İ, Madran B, Keske Ş, Karanfil Ö, Arribas JR, Pshenichnaya N, Petrosillo N, Gönen M, Ergönül Ö. Clin Microniol Infect., 2021 June; doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8. PMCID: PMC8186944. PMID: 34116205.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/EClinicalMedicine-The-Lancet-Logo.jpg
Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment

Naniche D, Hotez P, Bottazzi ME, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Batista C. EClinicalMedicine. 2021 Jun;36:100925. doi: 10.1016/j.eclinm.2021.100925. Epub 2021 Jun 3. PMID: 34099998; PMCID: PMC8173024.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/Science.of_.TE_.jpg
Existence of SARS-CoV-2 RNA on ambient particulate matter samples: A nationwide study in Turkey

Kayalar Ö, Arı A, Babuççu G, Konyalılar N, Doğan Ö, Can F, Şahin ÜA, Gaga EO, Levent Kuzu S, Arı PE, Odabaşı M, Taşdemir Y, Sıddık Cindoruk S, Esen F, Sakın E, Çalışkan B, Tecer LH, Fıçıcı M, Altın A, Onat B, Ayvaz C, Uzun B, Saral A, Döğeroğlu T, Malkoç S, Üzmez ÖÖ, Kunt F, Aydın S, Kara M, Yaman B, Doğan G, Olgun B, Dokumacı EN, Güllü G, Uzunpınar ES, Bayram H. Sci Total Environ. 2021 May 25;789:147976. doi: 10.1016/j.scitotenv.2021.147976. Epub ahead of print. PMID: 34058581; PMCID: PMC8144095.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/EClinicalMedicine-The-Lancet-Logo.jpg
Urgent needs to accelerate the race for COVID-19 therapeutics
Batista C, Shoham S, Ergonul O, Hotez P, Bottazzi ME, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow D, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Wilder-Smith A, Sow SO, Yadav P, Strub-Wourgaft N. EClinicalMedicine. 2021 May 23;36:100911. doi: 10.1016/j.eclinm.2021.100911. PMID: 34036254; PMCID: PMC8141354.
https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/atsjournals.jpg
Presence of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) RNA on Particulate Matters: A Multi Central Study in Turkey

Bayram H, Kayalar Ö, Arı A, Babuççu G, Konyalılar N, Doğan Ö, Can F, Gaga E, Kuzu L, Arı P, Odabaşı M, Taşdemir Y, Cindoruk S, Esen F, Sakin E, Calışkan B, Tecer L, Fıçıcı M, Altın A, Onat B, Ayvaz C, Kara M, Yaman B, Doğan G, Olgun B, Dokumacı E, Güllü G, Uzunpınar E, Şahin Ü. Am J Respir Crit Care Med. 2021 May; 203:A3080-A3080. doi: 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A3080

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/07/the.lancet_2.Logo_.png
Operation Warp Speed: implications for global vaccine security

Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. Lancet Glob Health. 2021 Jul;9(7):e1017-e1021. doi: 10.1016/S2214-109X(21)00140-6. Epub 2021 Mar 26. PMID: 33780663; PMCID: PMC7997645.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/EClinicalMedicine-The-Lancet-Logo.jpg
Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members

Hotez P, Batista C, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Strub-Wourgaft N, Yadav P, Bottazzi ME.  EClinicalMedicine. 2021 Mar;33:100780. doi: 10.1016/j.eclinm.2021.100780. Epub 2021 Mar 6. PMID: 33718854; PMCID: PMC7935671.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/JSO.jpg
Is elective cancer surgery feasible during the lock-down period of the COVID-19 pandemic? Analysis of a single institutional experience of 404 consecutive patients

Kulle CB, Azamat IF, Vatansever D, Erus S, Tarim K, Akyoldas G, Gokler O, Deveci MA, Cakar N, Ergonul O, Agcaoglu O, Kiremit MC, Yavuz O, Kiris T, Unsaler S, Giray B, Korkmaz M, Dilege E, Kilic M, Cesur E, Solaroglu I, Altuntas O, Simsek A, Tanju S, Erkan M, Canda E, Sasani M, Hafiz AM, Kordan Y, Balik E, Bilge O, Bugra D, Taskiran C, Dilege S.  J Surg Oncol. 2021 Jun;123(7):1495-1503. doi: 10.1002/jso.26436. Epub 2021 Feb 23. PMID: 33621377; PMCID: PMC8013582.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/CMI.jpg
What is the ‘new normal’ in surgical procedures in the era of COVID-19?

Cimen C, Keske Ş, Ergönül Ö. Clin Microbiol Infect. 2021 Jan;27(1):16-18. doi: 10.1016/j.cmi.2020.09.038. Epub 2020 Sep 30. PMID: 33007477; PMCID: PMC7525368.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/EMM.jpg
Physical rehabilitation in intensive care unit in acute respiratory distress syndrome patients with COVID-19

Ozyemisci Taskiran O, Turan Z, Tekin S, Senturk E, Topaloglu M, Yurdakul F, Ergonul O, Cakar N. Eur J Phys Rehabil Med. 2021 Jan 15. doi: 10.23736/S1973-9087.21.06551-5. Epub ahead of print. PMID: 33448757.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/BIO.jpg
Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection in vitro

Kayabolen A, Akcan U, Özturan D, Sarayloo E, Nurtop E, Özer B, Sahin GN, Doğan Ö, Lack N, Kaya M, Albayrak C, Can F, Solaroğlu İ, Bağcı-Önder T. BioRvix. Preprint posted online 2021 Jan. doi: 10.1101/2021.01.04.425128

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/07/the.lancet_Logo.png
Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics

Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. Lancet. 2021 Feb 13;397(10274):562-564. doi: 10.1016/S0140-6736(21)00242-7. Epub 2021 Jan 28. PMID: 33516284; PMCID: PMC7906712.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/IEEE.jpg
Molecular Communication Theoretical Modeling and Analysis of SARS-CoV2 Transmission in Human Respiratory System

Koca C, Civas M, Sahin SM, Ergonul O, Akan OB. IEEE Transactions on Molecular, Biological, and Multi-Scale Communications. 2021 Oca 1. https://doi.org/10.1109/TMBMC.2021.3071748

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/RS.jpg
Infectivity of Adult and Pediatric COVID-19 Patients

Kapmaz M, Doğan Ö, Aktürk H, Özer B, Nurtop E, Vatansever C, Özcan G, Çelikyurt A, Khalilova F, Okan A, İncir S, Sackesen C, Ergönül Ö, Can F. ResearchSquare. Preprint posted online 2020 Dec. doi: 10.21203/rs.3.rs-114148/v1.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/VACCINE.jpg
Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic

Keske Ş, Mutters NT, Tsioutis C, Ergönül Ö; EUCIC Vaccine. 2020 Dec 14;38(52):8357-8361. doi: 10.1016/j.vaccine.2020.11.003. Epub 2020 Nov 5. PMID: 33183855.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/IJID.jpg
Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?

Çelik HG, Keske Ş, Şener Ü, Tekbaş M, Kapmaz M, Şahin ŞT, Özyıldırım A, Aytekin S, Aytekin V, Ergönül Ö. Int J Infect Dis. 2021 Jan;102:389-391. doi: 10.1016/j.ijid.2020.10.080. Epub 2020 Oct 29. PMID: 33130195; PMCID: PMC7834514.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/FM.jpg
What Can We Estimate From Fatality and Infectious Case Data Using the Susceptible-Infected-Removed (SIR) Model? A Case Study of Covid-19 Pandemic

Ahmetolan S, Bilge AH, Demirci A, Peker-Dobie A, Ergonul O.Front Med (Lausanne). 2020 Sep 3;7:556366. doi: 10.3389/fmed.2020.556366. PMID: 33015109; PMCID: PMC7494820.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/CMI.jpg
National case fatality rates of the COVID-19 pandemic

Ergönül Ö, Akyol M, Tanrıöver C, Tiemeier H, Petersen E, Petrosillo N, Gönen M. Clin Microbiol Infect. 2021 Jan;27(1):118-124. doi: 10.1016/j.cmi.2020.09.024. Epub 2020 Sep 23. PMID: 32979575; PMCID: PMC7510430.

https://kuiscid.ku.edu.tr/wp-content/uploads/2021/06/IJID.jpg
Appropriate use of tocilizumab in COVID-19 infection

Keske Ş, Tekin S, Sait B, İrkören P, Kapmaz M, Çimen C, Uğur S, Çelebi İ, Bakır VO, Palaoğlu E, Şentürk E, Çağlayan B, Çakar N, Tabak L, Ergönül Ö.Int J Infect Dis. 2020 Oct;99:338-343. doi: 10.1016/j.ijid.2020.07.036. Epub 2020 Jul 26. PMID: 32726724; PMCID: PMC7382959.